b12 injection with lidocaine Vitamin Injection: Energy Boost and Anemia Treatment — Mountainside Medical Lidocaine HCl Injection 1% (10mg/mL)

A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007

Frequency and dosage depend on factors like medical condition, response to treatment, age, diet, and overall health

However, the oral administration of mecobalamin for the treatment of diabetic neuropathy was simultaneously initiated

The NHS does not set an upper safe limit for B12 because harmful effects from excessive intake have not been definitively established